New instrument from Horizon 2020 project will use OCT and MPT for high-resolution imaging. Piccolo project: the European consortium A project funded under the EU Horizon 2020 program aims to develop a novel endoscope for the identification and diagnosis of colorectal cancer, the latest step in the use of optical technologies to tackle one of the world's predominant cancers. Running for three years until December 2019, and involving nine European industrial and research partners led by Spain's Tecnalia Research & Innovation research center, the Piccolo project envisages an advanced endoscope instrument able to deliver high-resolution structural and functional imaging ...

The Institute of Biological and Medical Imaging at Helmholtz Zentrum München , Germany, is heading a research project entitled ”Hybrid optical and optoacoustic endoscope for esophageal tracking” or ESOTRAC . This four-year, €4 million, pan-European project will bring together engineers and physicians to develop a novel hybrid endoscopic instrument for early diagnosis and staging of esophageal cancer. The finished device is expected to reduce the number of unnecessary biopsies and, importantly, facilitate early-disease detection leading to earlier start of therapy, which will improve therapeutic efficacy over late-disease treatment and, ultimately, cost-savings for health care systems. ESOTRAC was awarded the €4 million ...

The BiOS Expo, part of SPIE's Photonics West event taking place this week in San Francisco, witnessed the unveiling of a new low-cost optical coherence tomography (OCT) scanner that developer Lumedica believes could dramatically extend the impact of the imaging technology for eye health. Founded in Durham, North Carolina, by an experienced team of engineers including chief scientist Adam Wax from Duke University, Lumedica’s debut scanner is priced at $10,000 – in a sector where entry-level equipment typically costs at least $35,000. Bottom-up design Wax explains that the low cost is achieved by using optical components already ...

Employer Description BEST in OPHTHALMOLOGY in the USA U.S. News & World Report has once again ranked Bascom Palmer as the Best in Ophthalmology for 2015-2016 . This is the 12th consecutive year we have received the #1 ranking in the annual Best Hospitals survey. Bascom Palmer has received the #1 ranking a remarkable fourteen times (1994, 1998, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, and 2016). Bascom Palmer’s Research Mission The future of ophthalmology lies in the creation of new knowledge and technology and its rapid translation into the clinic to help patients. Our ...

MIT project achieves 3D OCT over cubic-meter volumes. OCT on a bicycle: imaging cubic-meter volumes The value of optical coherence tomography (OCT) as a technique for micrometer-resolution sub-surface imaging is well established, with new applications now being added to its existing success in ophthalmology and medicine. Its imaging range has usually been restricted to a few centimeters, however, inevitably placing a limit on some of the potential uses for it that developers can envisage. A project group under OCT-pioneer James Fujimoto at MIT , and including industrial participants Thorlabs , has now drastically boosted that limit, and demonstrated 3D imaging over cubic-meter ...

Multiple UK and Danish partners involved in €4M effort to develop high-res system based around supercontinuum source . Glaucoma: high-res imaging needed for diagnosis Gooch & Housego and NKT Photonics are among eight partners from the UK and Denmark who have just started work on a new €4 million European project to develop a high-resolution optical coherence tomography (OCT) system for glaucoma diagnosis. The “GALAHAD” (short for Glaucoma - Advanced, Label-free High Resolution Automated OCT Diagnosis) effort, funded through the European Commission’s Horizon 2020 innovation platform, officially kicked off this month and runs for three years. High-res requirements Current OCT systems offer ...

Advances in silicon photonics development for datacom applications are set to be applied in biophotonics, with a new €4.9 million European project aiming to create a tiny and low-cost system for optical coherence tomography (OCT). While OCT has become widely used for ophthalmic diagnosis and is gaining traction in cardiovascular imaging, the technique still relies on relatively expensive and bulky combinations of laser, optical and electronic equipment. Now a team led by Wolfgang Drexler from the Medical University of Vienna is aiming to shrink the core technology to no more than the size of a coin, primarily to diagnose ...

OCT angiography moves beyond ophthalmic applications 10 May 2016 Wasatch Photonics platform brings the technique to a broader range of bioimaging uses. OCT angiography: structural and blood flow information. A new imaging platform launched by Wasatch Photonics aims to widen the range of applications for high-resolution optical coherence tomography angiography, and enhance the versatility of the technique for both researchers and OEM manufacturers. OCT angiography has already made inroads into clinical ophthalmology, where its non-invasive ability to provide both structural and blood-flow information via functional OCT without the need for fluorescent markers offers an attractive way to map retinal and ...

Researchers in New York have shown that a variation of optical coherence tomography (OCT) is able to tell melanomas apart from other skin lesions, by imaging the patterns of blood vessels that surround them. The small, early-stage study suggests that speckle-variance (sv) OCT could become a useful clinical tool for quickly identifying the most dangerous form of skin cancer, although a larger clinical trial of the technique will be needed to prove its utility first. Writing in the open access journal Dermatology Online , Orit Markowitz and colleagues looked at two pairs of malignant and benign lesions that are typically difficult ...

PIX4LIFE: (bio)photonic integrated circuits Introducing the “PIX4LIFE” effort at the same Brussels meeting, project co-ordinator Wolfgang Eberle from the IMEC electronics development institute in nearby Leuven said the focus would be on health and life science applications. PIX4LIFE will provide open access to CMOS-compatible silicon nitride (SiN) photonic integrated circuit (PIC) production technology, with a specific focus on biophotonics techniques including optical coherence tomography (OCT) and cytometry. Initial open access production runs are scheduled to begin before the end of 2017, but Eberle emphasized that ideas were already being sought. The €8.5 million project aims to showcase PIC-based ...

A research effort involving Laser Zentrum Hannover (LZH) in Germany is developing a new, laser-based treatment for presbyopia – the condition that impacts near vision in people from around the age of 40 onwards. At the moment presbyopia – caused by the age-related stiffening of the lens in those affected – is usually treated with simple solutions like reading or bifocal glasses, with multi-focal contact lenses from the likes of Bausch + Lomb becoming available more recently. Some laser procedures have also been developed, but if successful the LZH-led project could lead to a "gentle" new femtosecond laser technique that makes tiny cuts in ...

Carl Zeiss Meditec , the healthcare equipment division of the German optics giant Zeiss, has smashed its annual revenue target after posting sales in excess of €1 billion for the first time. At €1.04 billion, the publicly listed company’s revenues for the year ending September 30 were up 14 per cent on the previous 12 months . And although the weak euro currency accounts for nearly half of that growth rate, the result still saw the company’s stock price rise close to a 15-year high on the Frankfurt exchange. Leading the charge was Meditec’s surgical ophthalmology division, where ...

Opsens , the Canada-based producer of fiber-optic sensors, is aiming to raise C$5 million in a new public offering of shares on the Toronto Stock Exchange. News of the offering comes shortly after the Quebec-based firm announced plans to move into a new facility as it looked to ramp production in early 2016. Opsens says that it is selling around 5.7 million stock "units" in co-operation with lead agent Paradigm Capital, as well as RBC Capital Markets and M Partners, Inc. The cash is set to be used to "prepare the commercialization and marketing strategy" of its fiber-optic pressure ...

Despite the closure of the its Florida operations a year ago, the G&H ranks have since swelled, with the company employing some 700 people as of September 30 (up from 664 a year earlier). In his statement, Webster highlighted a more targeted effort in research and development, where the company is now focused on a smaller number of projects run by a global R&D group. With industrial applications still representing nearly 60 per cent of G&H sales in fiscal 2015, one of the company’s ongoing priorities is to generate more revenues from the life sciences. Sales ...

The capabilities of optical coherence tomography (OCT) as a non-contact imaging technique have become readily apparent since it first made inroads into ophthalmology clinics in the 1990s, but the inherent size and complexity of the instrumental platforms have conspired to keep it out of lower-cost or consumer-based applications. That may now be about to change, with the development of a new OCT platform christened multiple reference OCT (MR-OCT) by Compact Imaging , a California start-up with strong Irish connections. The company believes MR-OCT offers a way to bring the technique's biometric and imaging capabilities to applications where cost and form-factor ...

APPLICATIONS < Previous | Next > | Table of Contents Optical coherence tomography 'reducing heart attacks' 21 May 2015 Imaging technique appears to improve outcomes for cardiac patients being fitted with coronary stents, finds large-scale trial. OCT guidance Clinical trials to assess the effectiveness of optical coherence tomography (OCT) imaging ahead of cardiac stent surgery is helping physicians make better interventions, and leading to better patient outcomes – including a reduced rate of heart attacks. That’s according to St Jude Medical (SJM) , the US-based medical equipment company whose OCT technology is currently the subject of two large-scale studies. In those trials, conducted on more ...

US-based GSI Group says that its wide-ranging efforts to realign the business around laser, medical and precision motion technologies is now largely complete – following the sale of its fiber laser division JK Lasers to Trumpf subsidiary SPI Lasers last month . CEO John Roush told an investor conference call to discuss the Massachusetts firm’s latest financial results: “In the end, the high-power fiber laser materials processing application of JK did not have synergy with our other product lines, sales channels or infrastructure. So selling the business and redeployment the capital into our core businesses was definitely the right move for ...

Michelson Diagnostics , the UK-based medical device company focused on multi-beam Optical Coherence Tomography technology, has closed the £2.5m first tranche of its “Series B” financing, led by strategic investor and medical specialist Smith & Nephew alongside new investor Kent County Council as well as existing investors. The £2.5m investment will be used to expand Michelson Diagnostics’ commercial presence in Germany; launch the Company’s next generation VivoSight OCT tissue-imaging system; complete the ongoing US multi-center clinical biopsy avoidance study; and explore further applications in wound care and dentistry. VivoSight is a point-of-care tissue-imaging system that for the first time ...

Shares in Carl Zeiss Meditec , the clinical wing of the optics and microscopy giant, dropped in value by around 6 per cent on the Frankfurt stock exchange after the company just missed its annual sales target. For the year ending September 30, the Germany-headquartered firm delivered revenues of €909 million. That was up very slightly on the figure of €906 million for the previous year, but below the range of €910 million to €940 million estimated back in May – something blamed largely on currency effects. CEO Ludwin Monz said of the result: “In spite of adverse currency trends and to ...

UK firm Optos in potential £10M collaboration aiming for early detection of sight-threatening diseases. Optomap retinal imaging A new laser-based imaging technology for early detection of a range of serious eye diseases is set for a clinical study in the UK. Dunfermline-based Optos , which is listed on the London Stock Exchange, will work with Kent and Strathclyde Universities to develop a system that monitors the function of cells in patients’ eyes. The technology will then be used in clinical trials in Scotland, with the aim of detecting major sight-threatening diseases like glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy in ...

Despite the apparent saturation of optical coherence tomography systems in the ophthalmology markets of developed countries, the distinct OCT market for healthcare and life science sectors is still expected to grow from around €500 million in 2013 to around €1b in 2019. This is one of the conclusions of a new market sector report from analyst company Tematys , Paris, France. The report, Optical Coherence Tomography for Healthcare and Life Science: Technology and Market Trends , available from September 30, says that there will be “strong demand from new biomedical applications, continuous development of innovative OCT technologies, as well as strong demand ...

maging techniques that can reveal the direct effects of drugs on blood flow in the brain are a key to understanding the physiological underpinnings of drug abuse, and hence a potential route to superior treatments. Optical coherence Doppler tomography (ODT) is one promising answer, able to deliver quantitative visual information about the behavior of blood vessels, and provide valuable functional data about what happens to them under different stimuli and conditions. Researchers at Stony Brook University , New York, and the National Institutes of Health have now used the technique to image the effect of cocaine on cerebral blood flow in ...

Gareth Jones, the CEO who has overseen more than a decade of business expansion at Gooch & Housego (G&H) , is set to step down from the role at the end of this year. In a management succession plan announced in a statement to the London Stock Exchange (LSE), the UK-headquartered company said that Mark Webster would take over on January 1, 2015, following a spell as deputy CEO that will begin August 18. Currently serving on the company’s board as a non-executive director, Webster is a chemistry graduate and has spent more than two decades working in the healthcare ...

Super-resolution microscopes from Carl Zeiss and Leica Microsystems are among more than a dozen optics and photonics innovations to win one of this year’s R&D 100 Awards. Intended to recognize the 100 “most technologically significant products” introduced over the past year, the list also includes an all-fiber isolator from AdValue Photonics, an optical coherence tomography (OCT) diagnostic endoscope developed by NinePoint Medical, and a lunar laser communication system co-developed by NASA and MIT’s Lincoln Laboratory. In the microscopy sector, the R&D Magazine judging panel selected several winners, with Zeiss noted for the latest incarnation of its ...